169 related articles for article (PubMed ID: 23359827)
1. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
Barogui YT; Klis S; Bankolé HS; Sopoh GE; Mamo S; Baba-Moussa L; Manson WL; Johnson RC; van der Werf TS; Stienstra Y
PLoS Negl Trop Dis; 2013; 7(1):e2010. PubMed ID: 23359827
[TBL] [Abstract][Full Text] [Related]
2. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
[TBL] [Abstract][Full Text] [Related]
3. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.
Wadagni AC; Steinhorst J; Barogui YT; Catraye PM; Gnimavo R; Abass KM; Amofa G; Frimpong M; Sarpong FN; van der Werf TS; Phillips R; Sopoh GE; Johnson CR; Stienstra Y
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007866. PubMed ID: 31658295
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
[TBL] [Abstract][Full Text] [Related]
7. Assessment and Treatment of Pain during Treatment of Buruli Ulcer.
de Zeeuw J; Alferink M; Barogui YT; Sopoh G; Phillips RO; van der Werf TS; Loth S; Molenbuur B; Plantinga M; Ranchor AV; Stienstra Y
PLoS Negl Trop Dis; 2015; 9(9):e0004076. PubMed ID: 26402069
[TBL] [Abstract][Full Text] [Related]
8. Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
Ruf MT; Sopoh GE; Brun LV; Dossou AD; Barogui YT; Johnson RC; Pluschke G
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1334. PubMed ID: 21980547
[TBL] [Abstract][Full Text] [Related]
9. Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial.
Wadagni AC; Barogui YT; Johnson RC; Sopoh GE; Affolabi D; van der Werf TS; de Zeeuw J; Kleinnijenhuis J; Stienstra Y
Lancet Infect Dis; 2018 Jun; 18(6):650-656. PubMed ID: 29605498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity of Staphylococcus aureus in Buruli ulcer.
Amissah NA; Glasner C; Ablordey A; Tetteh CS; Kotey NK; Prah I; van der Werf TS; Rossen JW; van Dijl JM; Stienstra Y
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003421. PubMed ID: 25658641
[TBL] [Abstract][Full Text] [Related]
12. Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin.
Alferink M; de Zeeuw J; Sopoh G; Agossadou C; Abass KM; Phillips RO; Loth S; Jutten E; Barogui YT; Stewart RE; van der Werf TS; Stienstra Y; Ranchor AV
PLoS One; 2015; 10(6):e0119926. PubMed ID: 26030764
[TBL] [Abstract][Full Text] [Related]
13. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.
Lau JS; Kiss C; Roberts E; Horne K; Korman TM; Woolley I
Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):3. PubMed ID: 28100229
[TBL] [Abstract][Full Text] [Related]
15. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
[TBL] [Abstract][Full Text] [Related]
16. Management of BU-HIV co-infection.
O'Brien DP; Ford N; Vitoria M; Christinet V; Comte E; Calmy A; Stienstra Y; Eholie S; Asiedu K
Trop Med Int Health; 2014 Sep; 19(9):1040-7. PubMed ID: 24946829
[TBL] [Abstract][Full Text] [Related]
17. Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.
de Zeeuw J; Omansen TF; Douwstra M; Barogui YT; Agossadou C; Sopoh GE; Phillips RO; Johnson C; Abass KM; Saunderson P; Dijkstra PU; van der Werf TS; Stienstra Y
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3303. PubMed ID: 25392915
[TBL] [Abstract][Full Text] [Related]
18. Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.
de Zeeuw J; Douwstra M; Omansen TF; Sopoh GE; Johnson C; Phillips RO; Alferink M; Saunderson P; Van der Werf TS; Dijkstra PU; Stienstra Y
PLoS Negl Trop Dis; 2014; 8(11):e3254. PubMed ID: 25393289
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
